SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

In addition, in the coming years, oral GLP-1 receptor agonists and injectable formulations that require less-frequent ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Provides longer GLP-1 receptor activation. Depending on the medication, the effects can last for a minimum of 24 hours to a ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

This novel nanosystem can be used for the development of oral delivery of different peptidic drugs (including GLP-1/GLP-2 analogues, or others) that are in theory injected. The cost-effectiveness as ...

That means it could be dosed without considering meal timings, which is a consideration with some drugs in the oral GLP-1 class. For example, Novo Nordisk's oral formulation of semaglutide for dia ...

The diabetes meds in question are called GLP-1 RAs (sometimes abbreviated as GLP-1s). They include diabetes meds like ...

SAN JOSE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics” or "Rani”) (Nasdaq: ...